NCT01808300View on ClinicalTrials.gov

Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid.

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

Pregabalin 300mg, Thioctic acid 600mg

"* A: Pregabalin - Pregabalin 300mg will be administered orally twice a day for 3 days~* B: Thioctic acid - Thioctic acid 600mg will be administered orally once a day for 3 days~* C: Pregabalin plus Thioctic acid - Pregabalin plus Thioctic acid same way as A and B"

All Listed Sponsors
lead

Unimed Pharmaceuticals

INDUSTRY

NCT01808300 - Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid. | Biotech Hunter | Biotech Hunter